Related Experiment Video
Updated: May 22, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
In vitro-in vivo correlations: tricks and traps
1UFR Pharmacie, ERT-CIDAM, Biopharmaceutical Department, Auvergne University, Clermont-Ferrand, France. j-michel.cardot@u-clermont1.fr
This study explores common pitfalls in establishing in vitro-in vivo correlation (IVIVC). Understanding these limitations, such as data variability and model selection, is crucial for accurate formulation development.
Area of Science:
- Biopharmaceutical Sciences
- Drug Development
- Pharmacokinetics
Background:
- In vitro-in vivo correlation (IVIVC) is a valuable tool in pharmaceutical formulation development.
- Validated IVIVC can accelerate formulation design, establish dissolution specifications, and serve as a surrogate for in vivo studies.
- However, the application and interpretation of IVIVC are subject to specific limitations and potential errors.
Purpose of the Study:
- To identify and analyze five common challenges encountered during the establishment and utilization of IVIVC.
- To provide insights into potential sources of error that may compromise the reliability of IVIVC models.
- To guide researchers in avoiding common mistakes for more robust IVIVC development.
Main Methods:
- The study critically examines five specific areas where IVIVC can be limited:
- 1. Use of mean versus individual pharmacokinetic data.
- 2. Adjustments for absolute bioavailability.
- 3. Handling of lag time and time scaling in pharmacokinetic models.
- 4. Application of the flip-flop pharmacokinetic model.
- 5. Implementation of predictability corrections.
Main Results:
- Analysis reveals that inappropriate use of mean values, incorrect bioavailability corrections, and improper handling of lag time can significantly impact IVIVC.
- Misapplication of the flip-flop model and flawed predictability corrections can lead to erroneous conclusions.
- These factors collectively pose substantial risks to the validity and utility of IVIVC.
Conclusions:
- Careful consideration of data selection (mean vs. individual), bioavailability adjustments, and pharmacokinetic modeling parameters is essential for successful IVIVC.
- Avoiding common pitfalls in IVIVC development ensures its effective use as a predictive tool in pharmaceutical research.
- Addressing these limitations enhances the reliability of IVIVC for optimizing drug product performance.
More Related Videos
Related Concept Videos
Drug Product Performance: In Vitro–In Vivo Correlation
Equivalence: In Vitro and In Vivo Bioequivalence
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
In Vitro Drug Release Testing: Overview, Development and Validation
In vitro Mutagenesis

